Phase I trial of SU14813 in patients with advanced solid malignancies.
Standard
Phase I trial of SU14813 in patients with advanced solid malignancies. / Fiedler, Walter; Giaccone, G; Lasch, P; van der Horst, I; Brega, N; Courtney, R; Abbattista, A; Shalinsky, D R; Bokemeyer, Carsten; Boven, E.
in: ANN ONCOL, Jahrgang 22, Nr. 1, 1, 2011, S. 195-201.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Phase I trial of SU14813 in patients with advanced solid malignancies.
AU - Fiedler, Walter
AU - Giaccone, G
AU - Lasch, P
AU - van der Horst, I
AU - Brega, N
AU - Courtney, R
AU - Abbattista, A
AU - Shalinsky, D R
AU - Bokemeyer, Carsten
AU - Boven, E
PY - 2011
Y1 - 2011
N2 - this phase I, open-label, dose-escalation study investigated SU14813, an oral multitargeted tyrosine kinase inhibitor, in adults with solid tumors.
AB - this phase I, open-label, dose-escalation study investigated SU14813, an oral multitargeted tyrosine kinase inhibitor, in adults with solid tumors.
M3 - SCORING: Zeitschriftenaufsatz
VL - 22
SP - 195
EP - 201
JO - ANN ONCOL
JF - ANN ONCOL
SN - 0923-7534
IS - 1
M1 - 1
ER -